跳至主要内容
临床试验/JPRN-UMIN000005202
JPRN-UMIN000005202招募中未知

The effective switch from intensive insulin therapy to the once-daily human GLP-1 analogue liraglutide in patients with fairly well controlled type 2 diabetes - The effective switch from intensive insulin therapy to the once-daily human GLP-1 analogue liraglutide in patients with fairly well controlled type 2 diabetes

Department of Diabetes and Endocrinology, Kanto Rosai Hospital0 个研究点目标入组 20 人开始时间: 2011年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1, Subjects who have already been treated with oral hypoglycemic agents. 2, Subjects who are hypersensitive to this medicine and/or contaminants of this medicine. 3, Any condition that the investigator considers a potential obstacle to trial participation

研究者

发起方
Department of Diabetes and Endocrinology, Kanto Rosai Hospital

相似试验

The effective switch from intensive insulin therapy... | 临床试验